FormulaFolio Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FormulaFolio Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$12K	Hold	92	–	–	﹤0.01%	236
2021 Q1	$12K	Sell	92 -12,779	-99%	-$1.91M	﹤0.01%	234
2020 Q4	$1.81M	Buy	+12,871	New	+$1.65M	0.04%	258

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

FormulaFolio Investments's XBI Position: Q2 2021 in Review

FormulaFolio Investments held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2021 at 92 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

FormulaFolio Investments first reported a position in XBI in Q4 2020 and has held it in 3 quarters since. The position peaked at $1.81M in Q4 2020. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

FormulaFolio Investments held 92 shares of State Street SPDR S&P Biotech ETF worth $12K as of Q2 2021.
FormulaFolio Investments left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2021.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #236 holding.
FormulaFolio Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 3 quarters since.
FormulaFolio Investments's State Street SPDR S&P Biotech ETF position peaked at $1.81M in Q4 2020.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.